Literature DB >> 15937305

The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on 18F-FDG PET.

Mijin Yun1, Hyun Seok Choi, Eunhye Yoo, Jung Kyun Bong, Young Hoon Ryu, Jong Doo Lee.   

Abstract

UNLABELLED: Physiologic (18)F-FDG uptake in the stomach can often cause false-positive results and lowers the usefulness of (18)F-FDG PET in evaluating the remnant stomach. We assessed the role of gastric distension to see whether it is beneficial for the differentiation of recurrent tumors from physiologic (18)F-FDG uptake in the remnant stomach.
METHODS: Thirty patients (22 men and 8 women; age range, 27-80 y; mean age, 58.3 y) with a history of subtotal gastrectomy for gastric cancer underwent (18)F-FDG PET for various clinical indications. After whole-body imaging, the patients were asked to drink water, and then spot imaging of the stomach was performed. (18)F-FDG uptake in the remnant stomach was considered positive for malignancy if it was persistently increased, whether focal or diffuse, after water ingestion. We used 2 standardized uptake value (SUV) criteria to differentiate benign from malignant uptake. First, a lesion was considered benign if its SUV was less than 2 on whole-body imaging. Second, for a lesion with an SUV of 2 or above, it was classified as benign if SUV decreased by more than 10% after water ingestion.
RESULTS: Visual analysis of whole-body images produced 9 true-negative, 4 false-positive, 16 true-positive, and 1 false-negative results. Use of additional spot images produced 12 true-negative, 1 false-positive, 15 true-positive, and 2 false-negative results. When an SUV cutoff of 2 was applied for malignancy before water ingestion, all 17 patients with local recurrence were correctly identified, but 11 of the 13 patients without local recurrence were falsely considered to have a recurrent tumor in the remnant stomach. To reduce the false-positive results, we used the second SUV criterion after water ingestion. Use of that criterion produced 4 false-negative results although it correctly identified the 11 false-positive results as true negative.
CONCLUSION: Gastric distension by having patients drink a glass of water seems to be a simple, cost-effective way of improving the diagnostic accuracy of (18)F-FDG PET in patients with suspected recurrence in the remnant stomach. Visual analysis with special attention to the configuration of (18)F-FDG activity after water ingestion seems to be more useful than the change in SUV in evaluating the remnant stomach.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15937305

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  16 in total

Review 1.  Imaging of Gastric Cancer Metabolism Using 18 F-FDG PET/CT.

Authors:  Mijin Yun
Journal:  J Gastric Cancer       Date:  2014-03-31       Impact factor: 3.720

2.  Endoscopic submucosal dissection for early gastric cancer: quo vadis?

Authors:  Won Young Cho; Joo Young Cho; Il Kwun Chung; Jin Il Kim; Jin Seok Jang; Jae Hak Kim
Journal:  World J Gastroenterol       Date:  2011-06-07       Impact factor: 5.742

3.  Incremental diagnostic utility of gastric distension FDG PET/CT.

Authors:  Pierre-Yves Le Roux; Cuong P Duong; Carlos S Cabalag; Bimal K Parameswaran; Jason Callahan; Rodney J Hicks
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-10-21       Impact factor: 9.236

4.  Difference in F-18 FDG Uptake After Esophagogastroduodenoscopy and Colonoscopy in Healthy Sedated Subjects.

Authors:  Jong-Ryool Oh; Ji-Hyoung Seo; Woo-Jin Chang; Seung-Il Bae; In-Wook Song; Jin-Gu Bong; Hye-Yeon Jeong; So-Young Park; Jeongyup Bae; Hyundae Yoon
Journal:  Nucl Med Mol Imaging       Date:  2016-11-21

5.  Detectability of T-Measurable Diseases in Advanced Gastric Cancer on FDG PET-CT.

Authors:  Sun Young Oh; Gi Jeong Cheon; Young Chul Kim; Eugene Jeong; Seungeun Kim; Jae-Gol Choe
Journal:  Nucl Med Mol Imaging       Date:  2012-08-04

6.  Significance of SUV on Follow-up F-18 FDG PET at the Anastomotic Site of Gastroduodenostomy after Distal Subtotal Gastrectomy in Patients with Gastric Cancer.

Authors:  Byung Wook Choi; Seok Kil Zeon; Sung Hun Kim; Il Jo; Hae Won Kim; Kyoung Sook Won
Journal:  Nucl Med Mol Imaging       Date:  2011-09-09

7.  Pretreatment F-18 FDG PET/CT Parameters to Evaluate Progression-Free Survival in Gastric Cancer.

Authors:  Jeonghun Kim; Seok Tae Lim; Chang Ju Na; Yeon-Hee Han; Chan-Young Kim; Hwan-Jeong Jeong; Myung-Hee Sohn
Journal:  Nucl Med Mol Imaging       Date:  2013-11-28

Review 8.  Diagnosis and evaluation of gastric cancer by positron emission tomography.

Authors:  Chen-Xi Wu; Zhao-Hui Zhu
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

9.  The role of 18F-FDG PET/CT in the evaluation of gastric cancer recurrence after curative gastrectomy.

Authors:  Ji Eun Lee; Sung Pyo Hong; Dae Ho Ahn; Tae Joo Jeon; Min Kyung Kang; Chang Il Kwon; Kwang Hyun Ko; Seong Gyu Hwang; Pil Won Park; Kyu Sung Rim
Journal:  Yonsei Med J       Date:  2011-01       Impact factor: 2.759

Review 10.  Japanese Gastric Cancer Association Task Force for Research Promotion: clinical utility of ¹⁸F-fluoro-2-deoxyglucose positron emission tomography in gastric cancer. A systematic review of the literature.

Authors:  Hideaki Shimada; Shinichi Okazumi; Masamichi Koyama; Koji Murakami
Journal:  Gastric Cancer       Date:  2011-02-18       Impact factor: 7.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.